🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 53000N108
- Market Cap
- Small Cap · $249 Million
- IPO
- 11/1/2021 · $16.00/share
- ADR Ratio
- 1:1
Business: LianBio is a cross-border biotechnology company on a mission to bring transformative medicines to historically underserved patients in Greater China and other Asian markets. Through partnerships with highly innovative biopharmaceutical companies around the world, LianBio is advancing a diversified portfolio of product candidates with the potential to drive new standards of care across cardiovascular, oncology, ophthalmology, inflammatory disease and respiratory indications.
Company Contact
- CEO
- Yizhe Wang
- CFO
- Yi Larson
- Headquarters
- 103 Carnegie Center Drive, Suite 215, Princeton, NJ 08540
- Phone
- 609-486-2308
- Investor Relations
- Elizabeth Anderson · 646-655-8390 · elizabeth.anderson@lianbio.com